Australia - English - Department of Health (Therapeutic Goods Administration)

homatropine hydrobromide -

United States - English - NLM (National Library of Medicine)

alcon laboratories, inc. - hypromellose 2910 (4000 mpa.s) (unii: rn3152op35) (hypromellose 2910 (4000 mpa.s) - unii:rn3152op35) - lubricant uses - for the temporary relief of burning and irritation due to dryness of the eye. - for use as a protectant against further irritation. stop use and ask a doctor if - you experience eye pain - you experience changes in vision - you experience continued redness or irritation - the condition worsens or persists for more than 72 hours

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - pilocarpine hydrochloride -

United States - English - NLM (National Library of Medicine)

alcon laboratories, inc. - atropine sulfate (unii: 03j5ze7ka5) (atropine - unii:7c0697dr9i) - atropine sulfate 10 mg in 1 ml - isopto® atropine 1% is indicated for: atropine sulfate ophthalmic solution should not be used in anyone who has demonstrated a previous hypersensitivity or known allergic reaction to any ingredient of the formulation because it may recur. risk summary there are no adequate and well-controlled studies with isopto® atropine 1% administration in pregnant women to inform a drug-associated risk. adequate animal development and reproduction studies have not been conducted with atropine sulfate. in humans, 1% atropine sulfate is systemically bioavailable following topical ocular administration [see clinical pharmacology (12.3)] . isopto® atropine 1% should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus. there is no information to inform risk regarding the presence of atropine in human milk following ocular administration of isopto® atropine 1% to the mother. the effects on breastfed infants and the effects on milk production are also unknown.  the developmental a

Canada - English - Health Canada

novartis pharmaceuticals canada inc - pilocarpine hydrochloride - liquid - 1% - pilocarpine hydrochloride 1% - miotics

Canada - English - Health Canada

novartis pharmaceuticals canada inc - pilocarpine hydrochloride - liquid - 4% - pilocarpine hydrochloride 4% - miotics

Canada - English - Health Canada

novartis pharmaceuticals canada inc - pilocarpine hydrochloride - liquid - 2% - pilocarpine hydrochloride 2% - miotics

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

alcon -

Australia - English - Department of Health (Therapeutic Goods Administration)

carbachol -